
Ausnutria Dairy Corporation Ltd
1717.HKHKSEConsumer DefensivePackaged Foods
Latest quote
HK$1.285
+HK$0.05 · +4.05%
1717.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteAusnutria Dairy Corporation Ltd, an investment holding firm, is primarily involved in the entire lifecycle of infant formula and other dairy products, encompassing research and development, milk sourcing, processing, manufacturing, packaging, marketing, and distribution. Its operations are divided into two main divisions: Dairy and Related Products, and Nutrition Products. The company markets cow milk-based formula products under brand names such as Allnutria, Hyproca Hollary, Hyproca Hypure, Neolac, and Puredo. Additionally, its goat milk-based infant formula is sold under the Kabrita brand. Ausnutria also functions as an original equipment manufacturer (OEM) for formula milk powder products. Beyond dairy, it manufactures and distributes various nutrition products, develops and sells probiotic items, and offers financing solutions. Its global footprint spans the People's Republic of China, the European Union, Southeast Asia, Australia, New Zealand, the Middle East, North and South America, and other international markets. Established in 2003, Ausnutria Dairy Corporation Ltd is headquartered in Sheung Wan, Hong Kong, and operates as a subsidiary of HongKong Jingang Trade Holding Company Limited.
- Industry
- Packaged Foods
- Sector
- Consumer Defensive
- Headquarters
- HK
- CEO
- Zhijian Ren
- Listed since
- Oct 8, 2009
- Employees
- 3,095
Market position
- Volume
- 178K
- 0.8× average
- Average volume
- 222.06K
- Average daily volume
- Market cap
- 2.28B HKD
- Beta
- 0.29
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- 11.14×
- P/B (TTM)
- 0.32×
- P/S (TTM)
- 0.27×
- Dividend yield
- 3.89%
Profitability & efficiency
- Gross margin
- 38.64%
- Operating margin
- 2.87%
- Net margin
- 2.37%
Financial health
- Debt / equity
- 0.43×
- Altman Z-score
- 2.53
- Piotroski F-score
- 6 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.49B CNY | 7.4B CNY | 7.38B CNY | 7.8B CNY | 8.58B CNY |
| Cost of goods sold | 4.59B CNY | 4.29B CNY | 4.53B CNY | 4.4B CNY | 4.4B CNY |
| Gross profit | 2.89B CNY | 3.11B CNY | 2.85B CNY | 3.39B CNY | 4.15B CNY |
| Research and development | 105.41M CNY | 125.45M CNY | 132.03M CNY | 197.1M CNY | 193.16M CNY |
| Selling, general, and administrative | 2.57B CNY | 2.63B CNY | 2.44B CNY | 2.77B CNY | 2.93B CNY |
| Operating expenses | 2.72B CNY | 2.73B CNY | 2.57B CNY | 3.12B CNY | 3.2B CNY |
| Interest income | 37.83M CNY | 37.44M CNY | 35.71M CNY | 38.19M CNY | 28.1M CNY |
| Interest expense | 44.98M CNY | 51.64M CNY | 50.92M CNY | 21.75M CNY | 18.85M CNY |
| Depreciation and amortization | 281.32M CNY | 281.1M CNY | 250.67M CNY | 256.47M CNY | 277.05M CNY |
| Operating income | 170.44M CNY | 381.71M CNY | 281.68M CNY | 274.67M CNY | 953.1M CNY |
| Net income | 177.51M CNY | 235.98M CNY | 174.39M CNY | 216.53M CNY | 763.79M CNY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 0%
- 0 beats, 4 misses, 0 met estimates
- Average EPS surprise
- -85.68%
- 4 comparable reports
- Latest EPS result
- 0.05
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
HK$0.06
2025 complete year-77.8% since 2021
2026 partial: HK$0.05
HK$0.27
2,021
HK$0.56
2,022
HK$0.06
2,023
HK$0.05
2,024
HK$0.06
2,025
HK$0.05
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jun 2, 2026 | HK$0.05Annual | Jun 4, 2026 | Jun 25, 2026 |
Dividend | Jun 3, 2025 | HK$0.06Annual | Jun 5, 2025 | Jun 25, 2025 |
Dividend | Jun 4, 2024 | HK$0.05Annual | Jun 5, 2024 | Jun 25, 2024 |
Dividend | Jun 1, 2023 | HK$0.06Annual | Jun 2, 2023 | Jun 28, 2023 |
Dividend | May 30, 2022 | HK$0.56Annual | May 31, 2022 | Jun 23, 2022 |
Dividend | Jun 4, 2021 | HK$0.27Annual | Jun 7, 2021 | Jun 24, 2021 |
Ex-dividend Jun 2, 2026
HK$0.05
Annual
Record Jun 4, 2026 · Payment Jun 25, 2026
Ex-dividend Jun 3, 2025
HK$0.06
Annual
Record Jun 5, 2025 · Payment Jun 25, 2025
Ex-dividend Jun 4, 2024
HK$0.05
Annual
Record Jun 5, 2024 · Payment Jun 25, 2024
Ex-dividend Jun 1, 2023
HK$0.06
Annual
Record Jun 2, 2023 · Payment Jun 28, 2023
Ex-dividend May 30, 2022
HK$0.56
Annual
Record May 31, 2022 · Payment Jun 23, 2022
Ex-dividend Jun 4, 2021
HK$0.27
Annual
Record Jun 7, 2021 · Payment Jun 24, 2021
1717.HK peers
Continue in GoAI
Research 1717.HKresearch.disclaimer





